bioAffinity Technologies (BIAF) Non-Current Assets (2021 - 2026)

bioAffinity Technologies has disclosed Non-Current Assets across 6 years of filings, most recently posting $3.6 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 2.16% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $13.0 million (down 15.93% YoY), while the FY2025 annual figure was $3.4 million, down 11.08% from the prior year.
• Non-Current Assets grew to $3.6 million in Q1 2026, from $3.4 million in the prior quarter.
• Over the last five years, Non-Current Assets for BIAF reached as high as $4.2 million in Q4 2023 and fell as low as $7781.0 in Q3 2022.
• The 5-year median for Non-Current Assets is $3.6 million (2026), against an average of $2.8 million.
• Annual changes were most pronounced in 2023 — Non-Current Assets jumped 53611.03% — and 2025, when it decreased 26.73%.
• A 5-year view of Non-Current Assets shows it stood at $220438.0 in 2022, then jumped by 1827.44% to $4.2 million in 2023, then decreased by 10.13% to $3.8 million in 2024, then retreated by 11.08% to $3.4 million in 2025, then advanced by 6.13% to $3.6 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $3.6 million, $3.4 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.